DelMar Pharmaceuticals (NASDAQ: DMPI) Given a ‘Buy’ Rating and $16 Price Target by Aegis Capital
Biotechnology company DelMar Pharmaceuticals (NASDAQ: DMPI) has been given a ‘Buy’ rating by Aegis Capital Corp. and a $16 price…
Blog
MassRoots, Inc. (MSRT) Achieves Incredible Growth in 2016
MassRoots, Inc. (OTCQB: MSRT), a company offering cannabis enthusiasts the chance to share their cannabis content while staying connected with…
ChineseInvestors.com, Inc. (CIIX) Offers Unique Path to Global Chinese Investor and Consumer Market
Founded in 1999, and with offices in the U.S. and China, ChineseInvestors.com, Inc. (OTCQB: CIIX) acts as a growing Chinese-language…
GainClients, Inc. (GCLT) has Disruptive Marketing Solutions for Real Estate Professionals
GainClients, Inc. (OTC: GCLT) is disrupting the real estate marketing and advertising industry. Its GCard mobile technology platform ‘allows the…
Cytosorbents Corp. (NASDAQ: CTSO) Expected to Announce Doubling in Sales for 2016
Cytosorbents Corp. (NASDAQ: CTSO), a critical care-focused immunotherapy company engaged in the research, development, and commercialization of medical devices, most…
Aegis Restates ‘Buy’ Rating on Shares of Rosetta Genomics Ltd. (NASDAQ: ROSG)
Rosetta Genomics, Ltd. (NASDAQ: ROSG), a company in the business of developing and commercializing MicroRNA-based and other molecular diagnostics, recently…
Trevena, Inc. (NASDAQ: TRVN) Completes Phase 3 Apollo Trials for Oliceridine, Says Athena Study on Track
Trevena, Inc. (NASDAQ: TRVN), a clinical stage biopharmaceutical company, on January 4 announced it had completed enrollment for its Phase…
eXp World Holdings, Inc. (EXPI) Subsidiary eXp Realty Records 178% Increase in Agent Count During 2016
Before the opening bell, eXp World Holdings, Inc. (OTCQB: EXPI) announced final 2016 agent totals for subsidiary eXp Realty LLC,…
Senate Banking Committee Could Pave the Way to a Bankable Marijuana Industry
Last month, a letter signed by 10 U.S. senators arrived on the desk of Jamal El-Hindi, the acting director of…
Jaguar Animal Health, Inc. (NASDAQ: JAGX) Given Company Update by Aegis Capital Corp.
Jaguar Animal Health, Inc. (NASDAQ: JAGX), a company in the business of developing and commercializing gastrointestinal products for companion animals,…